ArticleCell reports. Medicine2023
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Francesco Di Meo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it